Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $18.95 million
- Book Value:
- Revenue TTM:
- $65.98 million
- Operating Margin TTM:
- Gross Profit TTM:
- $18.19 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Vapotherm Inc had its IPO on 2018-11-14 under the ticker symbol VAPO.
The company operates in the Healthcare sector and Medical Devices industry. Vapotherm Inc has a staff strength of 261 employees.
Shares of Vapotherm Inc opened at $3.6 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $3.44 - $3.74, and closed at $3.46.
This is a -1.98% slip from the previous day's closing price.
A total volume of 63,428 shares were traded at the close of the day’s session.
In the last one week, shares of Vapotherm Inc have increased by +11.97%.
Vapotherm Inc's Key Ratios
Vapotherm Inc has a market cap of $18.95 million, indicating a price to book ratio of 7.1053 and a price to sales ratio of 0.6375.
In the last 12-months Vapotherm Inc’s revenue was $65.98 million with a gross profit of $18.19 million and an EBITDA of $-56430000. The EBITDA ratio measures Vapotherm Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Vapotherm Inc’s operating margin was -92.94% while its return on assets stood at -34.03% with a return of equity of -686.69%.
In Q2, Vapotherm Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 23.6%.
Vapotherm Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-21.14 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vapotherm Inc’s profitability.
Vapotherm Inc stock is trading at a EV to sales ratio of 1.752 and a EV to EBITDA ratio of -1.2791. Its price to sales ratio in the trailing 12-months stood at 0.6375.
Vapotherm Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $90.08 million
- Total Liabilities
- $15.12 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Vapotherm Inc ended 2023 with $90.08 million in total assets and $0 in total liabilities. Its intangible assets were valued at $90.08 million while shareholder equity stood at $-34456000.00.
Vapotherm Inc ended 2023 with $0 in deferred long-term liabilities, $15.12 million in other current liabilities, 49000.00 in common stock, $-522880000.00 in retained earnings and $562000.00 in goodwill. Its cash balance stood at $18.00 million and cash and short-term investments were $18.00 million. The company’s total short-term debt was $2,706,000 while long-term debt stood at $101.82 million.
Vapotherm Inc’s total current assets stands at $56.58 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $8.92 million compared to accounts payable of $2.16 million and inventory worth $25.14 million.
In 2023, Vapotherm Inc's operating cash flow was $0 while its capital expenditure stood at $404000.
Comparatively, Vapotherm Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Vapotherm Inc stock is currently trading at $3.46 per share. It touched a 52-week high of $23.6544 and a 52-week low of $23.6544. Analysts tracking the stock have a 12-month average target price of $0.55.
Its 50-day moving average was $3.19 and 200-day moving average was $6.9 The short ratio stood at 4.16 indicating a short percent outstanding of 0%.
Around 1261.4% of the company’s stock are held by insiders while 5696.6% are held by institutions.
Frequently Asked Questions About Vapotherm Inc
Similar Industry Stocks (Medical Devices)
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.